These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epidemiology and prevention of cardiac failure: Framingham Study insights. Kannel WB Eur Heart J; 1987 Sep; 8 Suppl F():23-6. PubMed ID: 3665963 [TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. Kannel WB; Levy D; Cupples LA J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019 [TBL] [Abstract][Full Text] [Related]
6. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure. Kannel WB Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():199-212. PubMed ID: 9211012 [TBL] [Abstract][Full Text] [Related]
7. Need and prospects for prevention of cardiac failure. Kannel WB Eur J Clin Pharmacol; 1996; 49 Suppl 1():S3-9. PubMed ID: 8834926 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of heart failure. Kannel WB; Belanger AJ Am Heart J; 1991 Mar; 121(3 Pt 1):951-7. PubMed ID: 2000773 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of sudden death: insights from the Framingham Study. Kannel WB; McGee DL Cardiovasc Clin; 1985; 15(3):93-105. PubMed ID: 3833369 [TBL] [Abstract][Full Text] [Related]
11. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study. Kannel WB; Abbott RD Am Heart J; 1986 Feb; 111(2):391-7. PubMed ID: 2936230 [TBL] [Abstract][Full Text] [Related]
12. Cardiac failure and sudden death in the Framingham Study. Kannel WB; Plehn JF; Cupples LA Am Heart J; 1988 Apr; 115(4):869-75. PubMed ID: 3354416 [TBL] [Abstract][Full Text] [Related]
13. An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study. Kannel WB; McGee DL; Schatzkin A Drugs; 1984 Oct; 28 Suppl 1():1-16. PubMed ID: 6499693 [TBL] [Abstract][Full Text] [Related]
14. The progression from hypertension to congestive heart failure. Levy D; Larson MG; Vasan RS; Kannel WB; Ho KK JAMA; 1996 May 22-29; 275(20):1557-62. PubMed ID: 8622246 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic implications of left ventricular hypertrophy in arterial hypertension]. Kannel WB Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470 [TBL] [Abstract][Full Text] [Related]
16. Sudden coronary death in women. Kannel WB; Wilson PW; D'Agostino RB; Cobb J Am Heart J; 1998 Aug; 136(2):205-12. PubMed ID: 9704680 [TBL] [Abstract][Full Text] [Related]
17. Left ventricular hypertrophy as a risk factor: the Framingham experience. Kannel WB J Hypertens Suppl; 1991 Dec; 9(2):S3-8; discussion S8-9. PubMed ID: 1838765 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468 [TBL] [Abstract][Full Text] [Related]
19. Electrocardiographic Minnesota code findings predicting short-term mortality in asymptomatic subjects. The Italian RIFLE Pooling Project (Risk Factors and Life Expectancy). Menotti A; Seccareccia F G Ital Cardiol; 1997 Jan; 27(1):40-9. PubMed ID: 9199942 [TBL] [Abstract][Full Text] [Related]
20. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure]. Nogueira JB Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]